We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




UV Disinfecting Light Effective Against Resistant Superbugs

By HospiMedica International staff writers
Posted on 09 Aug 2019
Print article
Image: The Sentry M3 mobile UV disinfection unit (Photo courtesy of Puro Lighting).
Image: The Sentry M3 mobile UV disinfection unit (Photo courtesy of Puro Lighting).
Specialized ultraviolet (UV) disinfectant lighting products been shown to kill up to 99.9% of the deadly, multidrug resistant Candida auris fungus.

The Puro (Denver, CO, USA) Helo UV disinfectant lighting fixtures are designed to routinely disinfect a whole room from a fixed position, with broad spectrum UV light production that optimizes germ-killing efficiency. The fixtures can be operated manually, or integrated into a healthcare facility building automation system (BAS). The Sentry series, based on the same technology, is available in several mobile configurations that can be moved from room to room, deployed on uneven surfaces, and even placed on desktops and surfaces. Both can kill 99.9% of bacteria, viruses, mold, and fungus from a distance of three meters, including C. auris fungus.

The Puro fixtures were designed using exclusive patents and technology acquired from Violet Defense, which includes high intensity germicidal UV emission in the UV-C, UV-B, UV-A, and violet blue wavelengths. UV-C (200-280 nm) most efficiently kills bacteria, viruses, mold, and fungi; the UV-B (280-320nm) wavelength demonstrates effectiveness against specific bacteria; and UV-A (320-400 nm) causes oxidation of proteins and lipids, leading to cell death. Broadband UV lamps have also been shown to inhibit microbial photo-reactivation.

“Puro was formed in part to introduce new technologies and innovations in the fight against Healthcare Associated Infections (HAIs) caused by drug resistant superbugs such as C. auris,” said Jim Colantoni, co-founder and General Manager of Puro. “Our Helo and Sentry UV disinfecting products are an effective, new tool to fight HAIs, including this multidrug resistant fungus and reduce the suffering, loss of life, and treatment burden.”

C. auris fungus, a species of ascomycetous fungus that grows as a yeast, was first identified in Japan in 2009. It is of great concern due to multidrug resistance, difficulty to identify with standard laboratory methods, and previous outbreaks in healthcare settings. According to the U.S. Centers for Disease Control and Prevention, C. auris is able to survive on surfaces for weeks at a time, colonizing on high-touch areas such as hospital beds, windowsills and mobile medical equipment positioned in the room.

Related Links:
Puro

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Examination Table
Powerline Backrest Top

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.